In an interview with Pharm Exec’s Associate Editor Don Tracy, Carmen Villar, vice president of ESG and corporate citizenship at Gilead Sciences, discusses the new skills Generation Alpha brings to the pharmaceutical industry and the opportunities they face. Let’s talk about a certain difficulty.